SK130494A3 - Separating method of macrolide from acid, basic and unpolar neutral impurities - Google Patents

Separating method of macrolide from acid, basic and unpolar neutral impurities Download PDF

Info

Publication number
SK130494A3
SK130494A3 SK1304-94A SK130494A SK130494A3 SK 130494 A3 SK130494 A3 SK 130494A3 SK 130494 A SK130494 A SK 130494A SK 130494 A3 SK130494 A3 SK 130494A3
Authority
SK
Slovakia
Prior art keywords
macrolide
solvent
solution
immiscible
acidic
Prior art date
Application number
SK1304-94A
Other languages
English (en)
Slovak (sk)
Inventor
Constantine Gletsos
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of SK130494A3 publication Critical patent/SK130494A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/445—The saccharide radical is condensed with a heterocyclic radical, e.g. everninomycin, papulacandin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Pyrane Compounds (AREA)
  • Peptides Or Proteins (AREA)
SK1304-94A 1993-11-05 1994-10-27 Separating method of macrolide from acid, basic and unpolar neutral impurities SK130494A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14809693A 1993-11-05 1993-11-05

Publications (1)

Publication Number Publication Date
SK130494A3 true SK130494A3 (en) 1995-07-11

Family

ID=22524259

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1304-94A SK130494A3 (en) 1993-11-05 1994-10-27 Separating method of macrolide from acid, basic and unpolar neutral impurities

Country Status (25)

Country Link
US (1) US5508398A (ru)
EP (1) EP0652219B1 (ru)
JP (1) JP4202433B2 (ru)
KR (1) KR100393952B1 (ru)
CN (1) CN1037772C (ru)
AT (1) ATE202356T1 (ru)
AU (1) AU7759594A (ru)
BR (1) BR9404265A (ru)
CA (1) CA2134844C (ru)
CZ (1) CZ291865B6 (ru)
DE (1) DE69427513T2 (ru)
DK (1) DK0652219T3 (ru)
ES (1) ES2157239T3 (ru)
FI (1) FI112378B (ru)
GR (1) GR3036207T3 (ru)
HU (1) HU222576B1 (ru)
IL (1) IL111424A (ru)
NZ (1) NZ264852A (ru)
PT (1) PT652219E (ru)
RU (1) RU2152998C2 (ru)
SG (1) SG48919A1 (ru)
SK (1) SK130494A3 (ru)
TW (1) TW408125B (ru)
UA (1) UA41884C2 (ru)
ZA (1) ZA948641B (ru)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9618952D0 (en) 1996-09-11 1996-10-23 Sandoz Ltd Process
IT1289815B1 (it) * 1996-12-30 1998-10-16 Sorin Biomedica Cardio Spa Stent per angioplastica e relativo procedimento di produzione
GB9713730D0 (en) * 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds
PL374059A1 (en) * 2002-02-13 2005-09-19 Teva Gyogyszergyar Reszvenytarsasag Method for extracting a macrolide from biomatter
US7452692B2 (en) 2002-02-13 2008-11-18 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Method for extracting a macrolide from biomatter
EP1967520A2 (en) * 2002-07-16 2008-09-10 Biotica Technology Limited Production of polyketides and other natural products
DE04758730T1 (de) * 2003-03-31 2005-06-23 Biogal Gyogyszergyar Rt. Kristallisierung und Reinigung von Makroliden
US20060169199A1 (en) * 2003-03-31 2006-08-03 Vilmos Keri Crystallization and purification of macrolides
JP2007521013A (ja) 2003-07-24 2007-08-02 テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ マクロライドの精製方法
AU2003269473A1 (en) * 2003-08-26 2005-03-10 Biocon Limited A process for the recovery of substantially pure tricyclic macrolide
US20050112786A1 (en) * 2003-11-25 2005-05-26 Qing Wang Method of immobilizing a substance of interest to a solid phase
CA2548297C (en) * 2003-12-05 2011-06-14 Biocon Limited Process for the purification of macrolides
US20050197356A1 (en) * 2004-03-02 2005-09-08 Wyeth Non-immunosuppressive immunophilin ligands as neuroprotective and/or neuroregenerative agents
BRPI0508224A (pt) * 2004-03-02 2007-07-17 Wyeth Corp composto ou um sal farmaceuticamente aceitável do mesmo, cepa de actinomiceto, isolado de uma cepa, métodos para a produção de um macrolìdeo e de um composto, produto, composição, métodos de tratamento de um mamìfero e de um distúrbio neurológico, e, uso de um composto
JP4620405B2 (ja) * 2004-08-02 2011-01-26 アサヒビール株式会社 酵母変異株、グルタチオン高含有酵母の製造方法、その培養物、その分画物、酵母エキスおよびグルタチオン含有飲食品
AR050374A1 (es) 2004-08-20 2006-10-18 Wyeth Corp Forma polimorfica de rafampicina
ATE469908T1 (de) * 2004-12-01 2010-06-15 Teva Gyogyszergyar Zartkoeruen Verfahren zur herstellung von pimecrolimus
US20060149057A1 (en) * 2004-12-22 2006-07-06 Vilmos Keri Method of purifying macrolides
EP1833835A1 (en) * 2005-01-05 2007-09-19 Teva Gyogyszergyar Zartkoruen Müködö R Szv Nytarsa Amorphous tacrolimus and preparation thereof
DE602007006601D1 (de) * 2006-03-15 2010-07-01 Teva Gyogyszergyar Zartkoeruee Verfahren zur reinigung von tacrolimus
KR100740582B1 (ko) * 2006-09-27 2007-07-19 한국과학기술연구원 가스크로마토그래피-질량분석기를 이용한 두 생체시료군 간대사체 차별성 분석 방법
RU2009122202A (ru) * 2006-11-10 2010-12-20 Биокон Лимитед (In) Чистая форма рапамицина и способ ее выделения и очистки
CN102070652B (zh) * 2011-02-21 2012-05-02 西南大学 一种从发酵液中分离提取西罗莫司的方法
WO2014072984A1 (en) 2012-11-06 2014-05-15 Natco Pharma Limited Improved process for isolation and purification of rapamycin from fermentation broth
CN108976245B (zh) * 2017-11-09 2020-08-07 北大方正集团有限公司 一种雷帕霉素的提取方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993749A (en) * 1974-04-12 1976-11-23 Ayerst Mckenna And Harrison Ltd. Rapamycin and process of preparation
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US5091389A (en) * 1991-04-23 1992-02-25 Merck & Co., Inc. Lipophilic macrolide useful as an immunosuppressant
GB9125660D0 (en) * 1991-12-03 1992-01-29 Smithkline Beecham Plc Novel compound

Also Published As

Publication number Publication date
CA2134844A1 (en) 1995-05-06
HU222576B1 (hu) 2003-08-28
FI112378B (fi) 2003-11-28
CA2134844C (en) 2007-10-16
FI945186A0 (fi) 1994-11-03
KR950014311A (ko) 1995-06-15
HUT71122A (en) 1995-11-28
GR3036207T3 (en) 2001-10-31
ATE202356T1 (de) 2001-07-15
NZ264852A (en) 1995-12-21
DE69427513T2 (de) 2001-11-22
UA41884C2 (ru) 2001-10-15
BR9404265A (pt) 1995-07-04
PT652219E (pt) 2001-09-28
FI945186A (fi) 1995-05-06
CZ267494A3 (en) 1995-05-17
EP0652219B1 (en) 2001-06-20
DE69427513D1 (de) 2001-07-26
DK0652219T3 (da) 2001-08-27
CZ291865B6 (cs) 2003-06-18
ES2157239T3 (es) 2001-08-16
EP0652219A1 (en) 1995-05-10
HU9403164D0 (en) 1994-12-28
AU7759594A (en) 1995-05-18
CN1109058A (zh) 1995-09-27
JPH07184674A (ja) 1995-07-25
SG48919A1 (en) 1998-05-18
IL111424A0 (en) 1994-12-29
CN1037772C (zh) 1998-03-18
KR100393952B1 (ko) 2003-12-11
ZA948641B (en) 1996-05-02
RU94039281A (ru) 1997-03-27
IL111424A (en) 1999-10-28
TW408125B (en) 2000-10-11
US5508398A (en) 1996-04-16
JP4202433B2 (ja) 2008-12-24
RU2152998C2 (ru) 2000-07-20

Similar Documents

Publication Publication Date Title
SK130494A3 (en) Separating method of macrolide from acid, basic and unpolar neutral impurities
CZ54495A3 (en) Process for preparing and/or purification of clavulanic acid
US20100190975A1 (en) Method for purification of chlorinated sucrose derivatives by solvent extraction
US7473366B2 (en) Process for the purification of macrolides
KR20040086369A (ko) 바이오매터로부터 마크롤라이드를 추출하는 방법
KR100200239B1 (ko) 클라불란산 칼륨염의 제조방법
CN106883227B (zh) 通过麦角菌发酵废料制备麦角新碱的方法
US4014994A (en) Process for the recovery and purification of partricin
WO2006008302A2 (en) Improved process for the manufacture of mirtazapine
AU725281B2 (en) New extractive process for the recovery of naturally occurring macrolides
US4198344A (en) Process for the preparation of polyhydroxylated steroids, lysergol and ergolinic alkaloids
US6316657B1 (en) Process for purification or recovery of sweetener
US4331607A (en) Process for the purification of chenodeoxycholic acid
US6235775B1 (en) Acetone adduct of fungicidal V-28-3M
KR19980027016A (ko) 타우로우르소데옥시콜린산의 정제방법
KR100341355B1 (ko) 사이클로스포린a의제조방법
KR20070030923A (ko) 바이오매터로부터 마크롤라이드를 추출하는 방법
PL136958B1 (en) Method of isolation of polyfungine from the culture of highefficient mutant of streptomyces noursei var. polifungini strain